New insights for low dosing with the new P2Y12 inhibitors
- PMID: 25391907
- DOI: 10.1253/circj.cj-14-1166
New insights for low dosing with the new P2Y12 inhibitors
Erratum in
-
Corrigendum: new insights for low dosing with the new P2Y₁₂ inhibitors – lesson from the East.Circ J. 2015;79(1):223. doi: 10.1253/circj.CJ-66-0110. Circ J. 2015. PMID: 25744630 No abstract available.
Comment on
-
Prasugrel, a third-generation P2Y12 receptor antagonist, in patients with coronary artery disease undergoing elective percutaneous coronary intervention.Circ J. 2014;78(12):2926-34. doi: 10.1253/circj.cj-14-0266. Epub 2014 Oct 21. Circ J. 2014. PMID: 25342212 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
